BioNexus Gene Lab
BGLC
BGLC
1 hedge funds and large institutions have $29.4K invested in BioNexus Gene Lab in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
-2
Holders Change %
-66.67%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
+$29.4K |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$23.3K |
| 2 |
Two Sigma Investments
New York
|
-$8.4K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$5.6K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $29.4K | +$29.4K | +9,562 | New |
|
|
2
Citadel Advisors
Miami,
Florida
| – | -$23.3K | -9,877 | Closed |
|
|
3
Two Sigma Investments
New York
| – | -$8.4K | -3,553 | Closed |
|
|
4
Geode Capital Management
Boston,
Massachusetts
| – | -$5.6K | -2,368 | Closed |
|